{"id":16341,"date":"2021-11-25T13:08:50","date_gmt":"2021-11-25T11:08:50","guid":{"rendered":"https:\/\/zurnalsiepirkumi.lv\/?p=16341"},"modified":"2021-11-25T13:08:51","modified_gmt":"2021-11-25T11:08:51","slug":"antigena-pastestu-piegadatajs-izvelets-atbilstosi-zemakajai-cenai-un-isakajam-piegades-terminam","status":"publish","type":"post","link":"https:\/\/zurnalsiepirkumi.lv\/?p=16341","title":{"rendered":"Antig\u0113na pa\u0161testu pieg\u0101d\u0101t\u0101js izv\u0113l\u0113ts atbilsto\u0161i zem\u0101kajai cenai un \u012bs\u0101kajam pieg\u0101des termi\u0146am"},"content":{"rendered":"\n<p>Antig\u0113na pa\u0161testu pirm\u0101s partijas pieg\u0101d\u0101t\u0101js &#8220;Ekspress laboratorija&#8221; izv\u0113l\u0113ts atbilsto\u0161i zem\u0101kajai cenai un \u012bs\u0101kajam pieg\u0101des termi\u0146am, un uz\u0146\u0113mums ir p\u0101rbaud\u012bts starptautisko sankciju datu b\u0101z\u0113s, a\u0123ent\u016bra LETA noskaidroja Aizsardz\u012bbas ministrij\u0101 (AM).<\/p>\n\n\n\n<p>Valsts aizsardz\u012bbas lo\u0123istikas un\u00a0iepirkumu\u00a0centrs (VALIC) pirmo l\u012bgumu par Covid-19 slim\u012bbu izraiso\u0161\u0101 v\u012brusa (SARS-CoV-2) antig\u0113na pa\u0161testu pieg\u0101di nosl\u0113dzis ar uz\u0146\u0113mumu &#8220;Ekspress laboratorija&#8221; par kopum\u0101 tr\u012bs miljoniem eiro.<\/p>\n\n\n\n<p>AM runasv\u012brs Kaspars Galkins a\u0123ent\u016brai LETA skaidroja, ka saska\u0146\u0101 ar normat\u012bvajiem aktiem iepirkum\u0101 bija br\u012bvi \u013cauts pieteikties visiem ieinteres\u0113tajiem pieg\u0101d\u0101t\u0101jiem, t\u0101d\u0113j\u0101di nodro\u0161inot br\u012bvu un pla\u0161\u0101ku konkurenci.<\/p>\n\n\n\n<p>Sarunu proced\u016bras r\u012bko\u0161an\u0101 izmantota Vesel\u012bbas ministrijas izstr\u0101d\u0101t\u0101 tehnisk\u0101 specifik\u0101cija. Sarunu proced\u016br\u0101 pied\u0101v\u0101jumus iesniedza 30 pretendenti, no kuriem tikai 26 iesniedza pre\u010du paraugus, l\u012bdz ar to tika izskat\u012bti \u0161o 26 pretendentu pied\u0101v\u0101jumi.<\/p>\n\n\n\n<p>Sarunu proced\u016bras uzvar\u0113t\u0101ju noteik\u0161anai tika piem\u0113roti saimniecisk\u0101 izdev\u012bguma krit\u0113riji, p\u0113c kuriem tika izv\u0113l\u0113ti pieci komersanti, ar kuriem nosl\u0113gt visp\u0101r\u012bgo vieno\u0161anos, lai nodro\u0161in\u0101tu \u0101tr\u0101ku turpm\u0101k\u0101s vajadz\u012bbas apjomu ieg\u0101di, un noteikts saimnieciski visizdev\u012bg\u0101kais pied\u0101v\u0101jums, par kuru nosl\u0113gt pirmo pieg\u0101des l\u012bgumu par \u010detru miljonu pa\u0161testu pieg\u0101di.<br>V\u0113rt\u0113\u0161anas krit\u0113riji bija cena, kas veidoja 60% no\u00a0iepirkuma\u00a0\u012bpatsvara, un pieg\u0101des \u0101trums, kas veidoja 40% no \u012bpatsvara.<\/p>\n\n\n\n<p>Pirms l\u012bguma sl\u0113g\u0161anas ties\u012bbu pie\u0161\u0137ir\u0161anas tika veiktas visas likumos noteikt\u0101s p\u0101rbaudes, proti, veiktas p\u0101rbaudes Ministru kabineta noteiktaj\u0101 inform\u0101cijas sist\u0113m\u0101 &#8211; EIS, un piepras\u012bta inform\u0101cija visu ANO, Eiropas Savien\u012bbas, Latvijas nacion\u0101lo un ASV sankciju datub\u0101z\u0113.<br>Tas bija nepiecie\u0161ams, lai konstat\u0113tu, vai uz pretendentiem, uz\u0146\u0113mumu valdes locek\u013ciem, paties\u0101 labuma guv\u0113jiem, p\u0101rst\u0101v\u0113tties\u012bgaj\u0101m person\u0101m nav attiecin\u0101mi Starptautisko un Latvijas Republikas nacion\u0101lo sankciju likum\u0101 min\u0113tie p\u0101rk\u0101pumi.\u00a0<\/p>\n\n\n\n<p>&#8220;Attiec\u012bgi visp\u0101r\u012bg\u0101s vieno\u0161an\u0101s sl\u0113g\u0161anas ties\u012bbas ir pie\u0161\u0137irtas t\u0101diem komersantiem, kas atbilst publiskos\u00a0iepirkumus\u00a0regul\u0113jo\u0161ajiem normat\u012bvajiem aktiem, un nav bijis iemesla to noraid\u012b\u0161anai,&#8221; uzsv\u0113ra Galkins.<\/p>\n\n\n\n<p>Uz nor\u0101di, ka &#8220;Ekspress laboratorija&#8221; re\u0123istr\u0113ta vien \u0161\u0101 gada pavasar\u012b, Galkins atbild\u0113ja, ka uz\u0146\u0113muma dibin\u0101\u0161anas laiks nav noteikts ar ties\u012bbu aktiem k\u0101 viens no atlases krit\u0113rijiem, uz kura pamata pretendents b\u016btu izsl\u0113dzams vai glu\u017ei pret\u0113ji tiktu izv\u0113l\u0113ts k\u0101 atbilsto\u0161s.<\/p>\n\n\n\n<p>&#8220;Firmas.lv&#8221; inform\u0101cija liecina, ka medic\u012bnas pre\u010du tirgot\u0101js &#8220;Ekspress laboratorija&#8221; pieder Tomam Bindem, Je\u013cenai Putvi\u0137ei un Krievijas valstspieder\u012bgajam Sergejam \u013bebedevam. Uz\u0146\u0113mums re\u0123istr\u0113ts vien \u0161\u0101 gada pavasar\u012b, l\u012bdz ar to dati par t\u0101 finan\u0161u r\u0101d\u012bt\u0101jiem v\u0113l nav pieejami.<br>Uz\u0146\u0113mumam ir interneta m\u0101jaslapa &#8220;antigentest.lv&#8221;, kur\u0101 tiek pied\u0101v\u0101ts ieg\u0101d\u0101ties &#8220;\u0101trus un uzticamus Covid-19 Antigen testus uz\u0146\u0113mumiem, sporta klubiem, kult\u016bras iest\u0101d\u0113m, viesn\u012bc\u0101m, valsts iest\u0101d\u0113m, pa\u0161vald\u012bb\u0101m, medic\u012bnas iest\u0101d\u0113m, priv\u0101tperson\u0101m&#8221;, k\u0101 ar\u012b citas medic\u012bnas preces, tai skait\u0101 maskas, hal\u0101tus, cimdus, termometrus. Uz\u0146\u0113muma internetveikal\u0101 pied\u0101v\u0101to Covid-19 antig\u0113nu testu kl\u0101sts ir visai pla\u0161s, un l\u0113t\u0101kais no tiem maks\u0101 2,15 eiro.<\/p>\n\n\n\n<p>VALIC 9.novembr\u012b izsludin\u0101ja cenu aptauju par pa\u0161testu pieg\u0101di saska\u0146\u0101 ar Vesel\u012bbas ministrijas sagatavoto tehnisko specifik\u0101ciju. Kopum\u0101 tika sa\u0146emti 30 pied\u0101v\u0101jumi.<\/p>\n\n\n\n<p>P\u0113c iesniegto pied\u0101v\u0101jumu v\u0113rt\u0113\u0161anas pie\u0146emts l\u0113mums par visp\u0101r\u012bg\u0101s vieno\u0161an\u0101s sl\u0113g\u0161anu ar pieciem pretendentiem &#8211; &#8220;Ekspress laboratorija&#8221;, &#8220;Brief&#8221;, &#8220;ADDO Defense&#8221;, &#8220;A-birojs&#8221; un &#8220;A.Medical&#8221;.<\/p>\n\n\n\n<p>\u0160o pretendentu pied\u0101v\u0101t\u0101s cenas \u010detru miljonu testu pieg\u0101dei ir 0,75-1,25 eiro par testu, pieg\u0101des min\u0113tajam apjomam nodro\u0161inot piecu l\u012bdz 20 darba dienu laik\u0101 no l\u012bguma nosl\u0113g\u0161anas.<\/p>\n\n\n\n<p>Pl\u0101notais pirm\u0101s \u010detru miljonu testu partijas pieg\u0101des laiks ir piecas darba dienas un par \u0161\u012b\u00a0iepirkuma\u00a0uzvar\u0113t\u0101ju atz\u012bta &#8220;Ekspress laboratorija&#8221;. Kop\u0113j\u0101 l\u012bguma summa ir tr\u012bs miljoni eiro bez pievienot\u0101s v\u0113rt\u012bbas nodok\u013ca.<br>Ja tiks pie\u0146emts l\u0113mums palielin\u0101t ieg\u0101d\u0101jamo testu skaitu, tad attiec\u012bb\u0101 uz n\u0101kamo testu partiju pieg\u0101di notiks jauna uzvar\u0113t\u0101ja noteik\u0161ana starp min\u0113tajiem pieciem pretendentiem.<\/p>\n\n\n\n<p>No 6.decembra, veicot darba pien\u0101kumus kl\u0101tien\u0113, kur ir iesp\u0113jams kontakts ar citiem darbiniekiem, pakalpojuma sa\u0146\u0113m\u0113jiem vai apmekl\u0113t\u0101jiem, b\u016bs j\u0101veic regul\u0101ra Covid-19 test\u0113\u0161ana divas reizes ned\u0113\u013c\u0101, izmantojot antig\u0113na pa\u0161testus, paredz otrdien vald\u012bb\u0101 apstiprin\u0101tie groz\u012bjumi r\u012bkojum\u0101 par \u0101rk\u0101rt\u0113j\u0101s situ\u0101cijas izsludin\u0101\u0161anu.<\/p>\n\n\n\n<p>Pras\u012bba attieksies uz visiem darbiniekiem &#8211; gan pret Covid-19 vakcin\u0113tiem, gan nevakcin\u0113tiem.<\/p>\n\n\n\n<p>P\u0113c vald\u012bbas s\u0113des Valsts kancelejas direktors un Operat\u012bv\u0101s vad\u012bbas grupas vad\u012bt\u0101js J\u0101nis Citskovskis \u017eurn\u0101listiem nor\u0101d\u012bja, ka testus pamat\u0101 apmaks\u0101s valsts.<\/p>\n\n\n\n<p>L\u012bdz 6.decembrim atbild\u012bg\u0101s iest\u0101des sagatavos meh\u0101nismus k\u0101 \u0161os testus izplat\u012bt, un citas praktiskas deta\u013cas.<\/p>\n\n\n\n<p>P\u0113c s\u0101kotn\u0113j\u0101m apl\u0113s\u0113m testi Latvijai asto\u0146u ned\u0113\u013cu periodam var\u0113tu izmaks\u0101t apm\u0113ram 14 l\u012bdz 15 miljonus eiro.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Antig\u0113na pa\u0161testu pirm\u0101s partijas pieg\u0101d\u0101t\u0101js &#8220;Ekspress laboratorija&#8221; izv\u0113l\u0113ts atbilsto\u0161i zem\u0101kajai cenai un \u012bs\u0101kajam pieg\u0101des termi\u0146am, un uz\u0146\u0113mums ir p\u0101rbaud\u012bts starptautisko sankciju datu b\u0101z\u0113s.<\/p>\n","protected":false},"author":1938,"featured_media":16340,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"_links":{"self":[{"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/posts\/16341"}],"collection":[{"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/users\/1938"}],"replies":[{"embeddable":true,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16341"}],"version-history":[{"count":1,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/posts\/16341\/revisions"}],"predecessor-version":[{"id":16342,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/posts\/16341\/revisions\/16342"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=\/wp\/v2\/media\/16340"}],"wp:attachment":[{"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zurnalsiepirkumi.lv\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}